Dr. Masaki Nagamine, MD

Dr. Nagamine practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Nagamine's NPI, 1144751660, was assigned on March 26, 2017. Dr. Nagamine graduated from College of Human Medicine - Grand Rapids in 2017. Dr. Nagamine holds California license A160415.

Dr. Nagamine's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Nagamine's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagamine practices. Vendor and product names are available with a free account.

Vascular neurology is Dr. Nagamine's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Nagamine is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Nagamine is licensed in California.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, epilepsy, headaches, neuropathy, seizures and stroke among the conditions Dr. Nagamine treats.

CMS data shows 354 Medicare services from Dr. Nagamine across 5 procedure codes in 2024, for 199 Medicare patients. Medicare paid $44,052 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Dr. Nagamine in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagamine's median patient age at 59, with 53% women.

In 2024, Dr. Nagamine wrote 257 Medicare Part D claims for 49 patients. 84% of them were for generic drugs. CMS names the drug for 116 of them, across 6 drugs with 11 or more claims each, at $25,595 in total drug cost. In 2023, CMS named 83 claims across 4 drugs.

Dr. Nagamine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nagamine as offering telehealth.

Dmand AI links 16 papers to Dr. Nagamine, published from 2012 to 2024. 2012 was the busiest year, with 3. The most frequent topics are Pruritus, Histamine and Mice, Inbred C57BL. Dr. Nagamine has published most often in J Neurophysiol. Dr. Nagamine's most frequent co-authors are Auva Davoodi, MD, Wengui Yu, MD and Daniel S. Chow, MD.

Dmand AI links Dr. Nagamine to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hemorrhage, Ischemic Stroke and Pathological Conditions, Signs and Symptoms.

CMS Open Payments shows 3 general payments to Dr. Nagamine from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $34.

Dr. Nagamine serves on UCI Department of Neurology Grand Rounds Committee, UCI Department of Neurology Education Committee and UCI Department of Neurology Morbidity and Mortality Conference.

Dr. Nagamine graduated from College of Human Medicine - Grand Rapids in 2017. Dr. Nagamine is a member of AAN.

Dr. Nagamine is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.